Open AccessRothia mucilaginosa Infections in Pediatric Cancer Patients
Author(s) -
Rachel B Getzenberg,
Diego R. Hijano,
Hana Hakim,
Ronald H Dallas,
Jose Ferrolino,
Jessica N Brazelton,
Cherilyn D. Garner,
Tang Li,
Yin Su,
Joshua Wolf,
Randall T. Hayden,
Gabriela Maron
Publication year - 2020
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piaa047
Subject(s) - medicine , pediatric cancer , cancer , epidemiology , vancomycin , retrospective cohort study , intensive care medicine , gram positive bacterial infections , pediatrics , antibiotics , microbiology and biotechnology , staphylococcus aureus , biology , bacteria , genetics
We performed a retrospective study to determine the epidemiology of Rothia mucilaginosa infections among pediatric cancer patients. Over 20 years, 37 cases were identified; 27% developed complications, but there was no infection-related mortality. All cases were successfully treated with vancomycin.